191 related articles for article (PubMed ID: 31039060)
1. Change in Proportion of Days Covered for Statins Following Implementation of a Pharmacy Student Adherence Outreach Program.
Tamargo C; Sando K; Prados Y; Cowart K
J Manag Care Spec Pharm; 2019 May; 25(5):588-592. PubMed ID: 31039060
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence.
Abughosh SM; Vadhariya A; Johnson ML; Essien EJ; Esse TW; Serna O; Gallardo E; Boklage SH; Choi J; Holstad MM; Fleming ML
J Manag Care Spec Pharm; 2019 Oct; 25(10):1053-1062. PubMed ID: 31556824
[TBL] [Abstract][Full Text] [Related]
3. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
4. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics.
Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C
J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515
[TBL] [Abstract][Full Text] [Related]
5. A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence.
Abughosh S; Wang X; Serna O; Esse T; Mann A; Masilamani S; Holstad MM; Essien EJ; Fleming M
J Manag Care Spec Pharm; 2017 May; 23(5):549-560. PubMed ID: 28448784
[TBL] [Abstract][Full Text] [Related]
6. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
7. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
Lester CA; Mott DA; Chui MA
J Manag Care Spec Pharm; 2016 Jul; 22(7):801-7. PubMed ID: 27348281
[TBL] [Abstract][Full Text] [Related]
8. Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population.
Paolella D; Cherry E; Jolly JA; DeClercq J; Choi L; Zuckerman A
J Manag Care Spec Pharm; 2019 Nov; 25(11):1282-1288. PubMed ID: 31663457
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
10. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS
J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a pharmacist-driven medication adherence enhancement service.
Rinehart SN; Collins C; Glover J; Rice WM
J Manag Care Spec Pharm; 2021 Apr; 27(4):507-515. PubMed ID: 33769859
[No Abstract] [Full Text] [Related]
13. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
Majd Z; Mohan A; Paranjpe R; Abughosh SM
J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
[No Abstract] [Full Text] [Related]
14. Comprehensive Medication Management and Medication Adherence for Chronic Conditions.
Brummel A; Carlson AM
J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052
[TBL] [Abstract][Full Text] [Related]
15. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
[No Abstract] [Full Text] [Related]
16. Comparing adherence and persistence across 6 chronic medication classes.
Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico.
Hernández-Muñoz JJ; Wong ES; Kamdar CR
J Manag Care Spec Pharm; 2021 Mar; 27(3):392-398. PubMed ID: 33645248
[No Abstract] [Full Text] [Related]
18. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
[TBL] [Abstract][Full Text] [Related]
19. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
[TBL] [Abstract][Full Text] [Related]
20. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
